Zdrowie i gospodarka · 09/06/2020
FDA Releases Guidance for Institutional Review Boards Reviewing Individual Patient Expanded Access Requests for COVID-19 Treatments
The FDA has issued a final guidance to help Institutional Review Boards (IRBs) review individual patient expanded access requests for investigational COVID-19 treatments, allowing patients to access these treatments during the public health emergency.